RCUS
Arcus Biosciences Inc
25.10$
-5.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Arcus Biosciences Inc (RCUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -119 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -63 | -88 | -2.0 | -94 | 26 | -100 | -132 | -133 | -97 | -120 | -138 | -119 | -474 | |
| 1.0 | 3.0 | 3.0 | 2.0 | 2.0 | 3.0 | 3.0 | 2.0 | 2.0 | 3.0 | 2.0 | 3.0 | 10 | |
| 18 | 18 | 20 | 20 | 19 | 17 | 16 | 15 | 14 | 15 | 19 | 15 | 63 | |
| 16 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -9.0 | -24 | -37 | -19 | 101 | -23 | -37 | -148 | 21 | -30 | -31 | -47 | -87 | |
| 10 | 6.0 | 4.0 | 0.0 | 1.0 | 1.0 | 1.0 | 0.0 | 0.0 | 1.0 | 0.0 | 0.0 | 1.0 | |
| 11 | 28 | -169 | 63 | -29 | 51 | 32 | 137 | 79 | -182 | 114 | 52 | 63 | |
| – | – | – | -1.0 | 1.0 | – | – | – | – | – | – | – | – | |
| – | – | – | – | 47 | 0.0 | – | – | 0.0 | 0.0 | – | – | – | |
| 6.0 | 3.0 | 229 | 2.0 | 48 | -2.0 | 142 | 52 | 8.0 | 286 | 3.0 | 16 | 313 | |
| -46 | -57 | 58 | -29 | 45 | -51 | 42 | 56 | -10 | -16 | -21 | -51 | -98 | |
| -73 | -94 | -6.0 | -94 | 25 | -101 | -133 | -133 | -97 | -121 | -138 | -119 | -475 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.